NCT02942732View on ClinicalTrials.gov

Vitamin D Supplementation and Glycemic Outcomes

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Insulin Resistance
Interventions
DIETARY_SUPPLEMENT

cholecalciferol (Euro-Pharm International, Canada)

All assigned patients received a supplement of 10,000 IU cholecalciferol (Euro-Pharm International, Canada) to be taken three times per week. The treatment was led for a period of 6 months.

All Listed Sponsors
lead

Université d'Auvergne

OTHER

NCT02942732 - Vitamin D Supplementation and Glycemic Outcomes | Biotech Hunter | Biotech Hunter